{"filing":{"accession_number":"0001731122-26-000781","cik":"0001314052","ticker":"AVXL","company_name":"ANAVEX LIFE SCIENCES CORP.","form":"8-K","filing_date":"2026-05-22","report_date":null,"primary_document":"e7667_8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226000781/e7667_8-k.htm"},"events":[{"id":10734,"run_id":9416,"accession_number":"0001731122-26-000781","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.94,"summary":"Anavex received a delinquency notification from Nasdaq on May 20, 2026, for failure to timely file its Form 10-Q, triggering non-compliance with Nasdaq Listing Rule 5250(c)(1). The company has until July 20, 2026, to submit a compliance plan and until November 16, 2026, to regain compliance, or face potential delisting proceedings.","company_name":"ANAVEX LIFE SCIENCES CORP.","ticker":"AVXL","filing_date":"2026-05-22","submitted_at":null,"items":[{"id":7119,"accession_number":"0001731122-26-000781","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued Listing","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"Anavex received a delinquency notification from Nasdaq on May 20, 2026, for failure to timely file its Form 10-Q, placing the company in non-compliance with Nasdaq Listing Rule 5250(c)(1). The company has until July 20, 2026, to submit a compliance plan and until November 16, 2026, to regain compliance, or face potential delisting proceedings. This is a material disclosure of delisting risk that would significantly affect investor assessment of the registrant's continued trading status.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:59:05.209634+00:00","company_name":"","ticker":null,"filing_date":""},{"id":7120,"accession_number":"0001731122-26-000781","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The filing discloses receipt of a \"Notice\" and explicitly references the Company's plans to \"regain compliance with Nasdaq Listing Rule 5250(c)(1),\" which is the rule governing timely filing of periodic reports. The forward-looking statements identify risks related to the Company's ability to file the Form 10-Q and regain compliance, indicating a delisting risk triggered by non-compliance with continued listing standards.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:59:05.209634+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7119,"accession_number":"0001731122-26-000781","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued Listing","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"Anavex received a delinquency notification from Nasdaq on May 20, 2026, for failure to timely file its Form 10-Q, placing the company in non-compliance with Nasdaq Listing Rule 5250(c)(1). The company has until July 20, 2026, to submit a compliance plan and until November 16, 2026, to regain compliance, or face potential delisting proceedings. This is a material disclosure of delisting risk that would significantly affect investor assessment of the registrant's continued trading status.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:59:05.209634+00:00","company_name":"ANAVEX LIFE SCIENCES CORP.","ticker":"AVXL","filing_date":"2026-05-22"},{"id":7120,"accession_number":"0001731122-26-000781","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The filing discloses receipt of a \"Notice\" and explicitly references the Company's plans to \"regain compliance with Nasdaq Listing Rule 5250(c)(1),\" which is the rule governing timely filing of periodic reports. The forward-looking statements identify risks related to the Company's ability to file the Form 10-Q and regain compliance, indicating a delisting risk triggered by non-compliance with continued listing standards.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:59:05.209634+00:00","company_name":"ANAVEX LIFE SCIENCES CORP.","ticker":"AVXL","filing_date":"2026-05-22"}]}